Zydus supplies first batch of 30,000 Covid Kavach Elisa tests to ICMR



The first batch of 30,000 Covid Kavach Elisa tests manufactured by Zydus Diagnostics has been supplied to Indian Council of Medical Research (ICMR) free of cost.
These test kits have been manufactured in technology transfer with ICMR-National Institute of Virology (NIV) of Pune for surveillance purposes, said Zydus Diagnostics (a unit of Cadila Healthcare Ltd) in a statement on Thursday.
Robust antibody tests are critical for surveillance and understanding the proportion of the population exposed to SARS Cov-2 infection. ICMR-NIV has successfully developed an indigenous IgG Elisa test for anti-body detection for Covid-19. Read More

Comments

Popular posts from this blog

3 Investment Strategies for Financial Independence!

Instagram adds group video call, new camera effects to app: How they work

G7 pledges 870 mn Covid vaccine doses, half to be delivered by 2021-end